Vaxcyte, Inc. (PCVX)
↓ Download CSVKey ratios (FY2025)
-28.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$923.67M | -$569.55M | -$468.04M | -$232.26M | -$103.67M | -$89.58M | -$54.15M | -$35.53M | — |
| Net Income | -$766.63M | -$463.93M | -$402.27M | -$223.49M | -$100.08M | -$89.22M | -$50.27M | -$29.48M | — |
| EPS (Diluted) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | $-1.93 | $-3.02 | — | — | — |
| Total Assets | $3.00B | $3.51B | $1.41B | $1.01B | $324.34M | $392.83M | $65.70M | — | — |
| Total Liabilities | $317.21M | $205.50M | $167.45M | $52.56M | $40.32M | $46.98M | $11.76M | — | — |
| Shareholders' Equity | $2.69B | $3.31B | $1.24B | $953.61M | $284.02M | $345.84M | -$106.37M | -$57.73M | -$29.13M |
| Cash & Equivalents | $173.96M | $387.88M | $397.45M | $834.66M | $68.98M | $386.20M | $58.98M | — | — |
| Operating Cash Flow | -$655.58M | -$452.63M | -$296.79M | -$170.60M | -$121.39M | -$46.63M | -$47.15M | -$30.47M | — |
| Capital Expenditures | $13.71M | $22.43M | $16.06M | $5.84M | $6.55M | $1.16M | $1.20M | $1.77M | — |
| Shares Outstanding | 131.06M | 124.89M | 95.36M | 79.47M | 53.03M | 51.07M | 4.06M | — | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — |